CoChat

Does 1,25(OH)2D3 Accelerate Spinal Bone Loss?: A Controlled Therapeutic Trial in 70-year-old Women

Finn, Grethe, Meinecke, Birgit, Boesen, Jens, TRANSBØL, IB · 1985 · Clinical Orthopaedics and Related Research
Cited by 43

The DOI matches its Crossref record.

Abstract

The progress of spinal bone loss was monitored by measurements of the vertebral body height of T6 to L5 in seventy 70-year-old women who participated in a controlled, double-blind therapeutic trial. They were treated for one year by 1,25(OH)2D3, 0.50 micrograms a day (or less if hypercalcemia occurred) and cyclical estrogen/gestagen, alone or combined, or placebo. Sufficient calcium intake was ensured in all. The vertebral body height decreased significantly, by 1%, in both of the 1,25(OH)2D3 groups, whereas it remained unchanged in the hormone and the placebo + calcium group. This observation does not encourage the use of 1,25(OH)2D3 for prevention or treatment of postmenopausal bone loss.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00003086-198501000-00030

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 43

Metadata

Authors
Finn, G., Meinecke, B., Boesen, J., & TRANSBØL, I.
Venue
Clinical Orthopaedics and Related Research
Published
1985-01
Volume
192
Issue
192
Pages
215-221
ISSN
0009-921X (ISSN-L)
OpenAlex
W1978741172
Cited by
43
References
0
FWCI
0.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does 1,25(OH)2D3 Accelerate Spinal Bone Loss?: A Controlled Therapeutic Trial in 70-year-old Women. https://app.cochat.ai/papers/10.1097/00003086-198501000-00030
The paper
Finn, G., Meinecke, B., Boesen, J., & TRANSBØL, I. (1985). Does 1,25(OH)2D3 Accelerate Spinal Bone Loss?: A Controlled Therapeutic Trial in 70-year-old Women. Clinical Orthopaedics and Related Research. https://doi.org/10.1097/00003086-198501000-00030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.